Alzheimer disease

16 · 20 / page

Ask MedXY AI

Latest news

Tag

NeurologyLATE-NCdementia

Alzheimer and LATE-NC Pathologies Associated With Timely Dementia Diagnosis in Healthcare Settings

By MedXY|Jul 26, 2026

Among older adults with incident dementia, Alzheimer disease and LATE-NC pathologies were independently linked to higher odds of receiving a timely diagnosis, while vascular pathology and Lewy bodies showed no significant association.

Long-Term Economic Impact of Early-Onset Dementia: A 15-Year Retrospective Analysis of Income and Productivity Loss

NeurologyAlzheimer diseaseEarly-onset dementia

Alzheimer disease

Latest news

Alzheimer and LATE-NC Pathologies Associated With Timely Dementia Diagnosis in Healthcare Settings

Long-Term Economic Impact of Early-Onset Dementia: A 15-Year Retrospective Analysis of Income and Productivity Loss

Retinal Microvascular Clues to Alzheimer Disease: What Swept-Source OCT Angiography Reveals About Neurovascular Dysfunction

A Two-Marker Plasma Model Closely Mirrors PET-Based Biological Staging of Alzheimer Disease

Midlife Central Obesity Tracks With Higher Late-Life Plasma P-tau217 and Biomarker-Verified Alzheimer Dementia, While the Association Reverses in Old Age

Dementia Screening for Family Members: No Clear Benefit or Harm Found in Landmark Trial

Why Women Show Higher Amyloid Burden: New Evidence on Sex, Race, and APOE ε4 Interactions in Alzheimer’s Pathology

Sex, Race, and Ancestry Converge to Shape Amyloid Pathology: Evidence from a Large-Scale Admixed Autopsy Study

Higher Serum Klotho Levels May Protect Cognitive Function Against Age-Related Brain Atrophy

Precision Screening for Preclinical Alzheimer Disease: The Ascendance of Plasma p-tau217 as a Scalable Biomarker

Home-Based Gamma tACS Improves Cognitive Function and Daily Living in Alzheimer Disease: Results from a Randomized Clinical Trial

White Matter Microstructure and Cognitive Decline in Aging and Alzheimer Disease: A Comprehensive Review of Recent Advances

Free Water Collapse in Limbic White Matter Predicts Memory Decline in Aging and Alzheimer Disease

Lower Posttreatment Amyloid Predicts Slower Clinical Decline and Reduced Tau/Glial Biomarkers After Donanemab: Secondary Analysis of TRAILBLAZER‑ALZ 2

Dietary Patterns and Dementia Risk: Insights from a Large UK Biobank Cohort Study

Enlarged Perivascular Spaces as Early Neurovascular Biomarkers in Alzheimer Disease: Integrating Serum and MRI Findings from Multicultural Cohorts